D-Index & Metrics Best Publications
Medicine
Finland
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 40,252 446 World Ranking 4172 National Ranking 49

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Finland Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of study are Breast cancer, Internal medicine, Cancer, Pathology and Genome-wide association study. His Breast cancer study incorporates themes from Single-nucleotide polymorphism, Genotype, Case-control study and Genetic predisposition. The various areas that Veli-Matti Kosma examines in his Internal medicine study include Endocrinology and Oncology.

His studies in Cancer integrate themes in fields like Survival rate, Cancer research and PALB2. His Pathology research focuses on subjects like Survival analysis, which are linked to Melanoma. His study in Genome-wide association study is interdisciplinary in nature, drawing from both TOX3, Disease, Genetic association and Bioinformatics.

His most cited work include:

  • Genome-wide association study identifies novel breast cancer susceptibility loci (2045 citations)
  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk (834 citations)
  • MicroRNA related polymorphisms and breast cancer risk (582 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Breast cancer, Internal medicine, Pathology, Oncology and Cancer. Veli-Matti Kosma has researched Breast cancer in several fields, including Single-nucleotide polymorphism, Genome-wide association study and Genotype. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.

As a part of the same scientific study, Veli-Matti Kosma usually deals with the Pathology, concentrating on Cancer research and frequently concerns with Carcinogenesis, Metastasis and Tumor suppressor gene. His Oncology research incorporates elements of Genetic predisposition, Case-control study, Ovarian cancer, Proportional hazards model and Gynecology. His Stromal cell study combines topics from a wide range of disciplines, such as Cancer cell, Stroma and CD44.

He most often published in these fields:

  • Breast cancer (42.05%)
  • Internal medicine (39.65%)
  • Pathology (35.95%)

What were the highlights of his more recent work (between 2013-2021)?

  • Breast cancer (42.05%)
  • Oncology (26.80%)
  • Internal medicine (39.65%)

In recent papers he was focusing on the following fields of study:

Veli-Matti Kosma mainly investigates Breast cancer, Oncology, Internal medicine, Genome-wide association study and Single-nucleotide polymorphism. His Breast cancer research is multidisciplinary, relying on both Genotype and Bioinformatics. His Oncology study integrates concerns from other disciplines, such as Odds ratio, Ovarian cancer, Proportional hazards model, Gynecology and Prospective cohort study.

Veli-Matti Kosma frequently studies issues relating to Pathology and Internal medicine. Veli-Matti Kosma has included themes like Genetic predisposition, Case-control study, Genotyping, Genetic association and Minor allele frequency in his Genome-wide association study study. The Single-nucleotide polymorphism study combines topics in areas such as Artificial intelligence, Haplotype and Candidate gene.

Between 2013 and 2021, his most popular works were:

  • MicroRNA related polymorphisms and breast cancer risk (582 citations)
  • Association analysis identifies 65 new breast cancer risk loci (569 citations)
  • Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche (391 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His scientific interests lie mostly in Breast cancer, Genome-wide association study, Internal medicine, Oncology and Genetics. His research in Breast cancer intersects with topics in Odds ratio, Case-control study, Genotype and Bioinformatics. The study incorporates disciplines such as Mendelian randomization, Genetic predisposition and Locus in addition to Genome-wide association study.

His Genetic predisposition research includes elements of MiRNA binding, microRNA and Genetic variation. His study focuses on the intersection of Internal medicine and fields such as Pathology with connections in the field of Cancer. His work deals with themes such as Tongue, Pancreatic cancer, Proportional hazards model, Stage and Risk factor, which intersect with Oncology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Genome-wide association study identifies novel breast cancer susceptibility loci

Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Nature (2007)

2713 Citations

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)

1179 Citations

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)

969 Citations

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)

855 Citations

A common coding variant in CASP8 is associated with breast cancer risk

Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian.
Nature Genetics (2007)

667 Citations

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

Päivi Auvinen;Raija Tammi;Jyrki Parkkinen;Markku Tammi.
American Journal of Pathology (2000)

667 Citations

MicroRNA related polymorphisms and breast cancer risk

Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)

629 Citations

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)

604 Citations

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush.
American Journal of Human Genetics (2019)

571 Citations

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius.
Nature Genetics (2015)

560 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Veli-Matti Kosma

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 280

Douglas F. Easton

Douglas F. Easton

University of Trieste

Publications: 222

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 221

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 191

Melissa C. Southey

Melissa C. Southey

Monash University

Publications: 179

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 174

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 162

Esther M. John

Esther M. John

Stanford University

Publications: 154

Peter Kraft

Peter Kraft

Harvard University

Publications: 147

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 146

Wei Zheng

Wei Zheng

Vanderbilt University Medical Center

Publications: 143

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 135

Christopher A. Haiman

Christopher A. Haiman

University of Southern California

Publications: 134

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 125

Alison M. Dunning

Alison M. Dunning

University of Cambridge

Publications: 125

David J. Hunter

David J. Hunter

University of Oxford

Publications: 123

Trending Scientists

Alfred Ramani

Alfred Ramani

Université Paris Cité

David J. Steigmann

David J. Steigmann

University of California, Berkeley

Hou Chengyi

Hou Chengyi

Donghua University

Piyasan Praserthdam

Piyasan Praserthdam

Chulalongkorn University

Vladimir G. Dubrovskii

Vladimir G. Dubrovskii

St Petersburg University

Xiaoyang Xu

Xiaoyang Xu

New Jersey Institute of Technology

Krishna V. Subbarao

Krishna V. Subbarao

University of California, Davis

Kok-Gan Chan

Kok-Gan Chan

University of Malaya

Brian J. Lipworth

Brian J. Lipworth

University of Dundee

Enrico Cherubini

Enrico Cherubini

International School for Advanced Studies

Seth M. Noar

Seth M. Noar

University of North Carolina at Chapel Hill

Sarah H. Wild

Sarah H. Wild

University of Edinburgh

George J. Klein

George J. Klein

University of Western Ontario

Ingalill Rahm Hallberg

Ingalill Rahm Hallberg

Lund University

Yot Teerawattananon

Yot Teerawattananon

Health Intervention and Technology Assessment Program

Charles Darwin

Charles Darwin

University of Edinburgh

Something went wrong. Please try again later.